Home › Melanoma › Virginia › Roanoke
Melanoma clinical trials in Roanoke, VA
4 studies for Melanoma are looking for participants at sites in and around Roanoke (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RecruitingPhase 3
- Oncology & Hematology Associates of Southwest Virginia, Inc., Roanoke
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Carilion Children's, Roanoke
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Carilion Roanoke Memorial Hospital, Roanoke
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Recruiting
- Carilion Roanoke Memorial Hospital, Roanoke
About Melanoma
Melanoma is the most serious type of skin cancer. Most have a black or black-blue area. Learn the 'ABCDE' of what to watch for and treatment options.
More about Melanoma on MedlinePlus
Melanoma trials in other cities
- Houston, TX59 studies
- New York City, NY38 studies
- Los Angeles, CA34 studies
- Nashville, TN33 studies
- Pittsburgh, PA31 studies
- Boston, MA26 studies
- Philadelphia, PA23 studies
- San Francisco, CA22 studies
- Durham, NC21 studies
- Atlanta, GA21 studies
- St. Louis, MO21 studies
- Salt Lake City, UT21 studies
Other studies in Roanoke
- Colorectal Cancer10 studies
- Heart Failure9 studies
- Non-Small Cell Lung Cancer8 studies
- Prostate Cancer7 studies
- Breast Cancer7 studies
- Metastatic Cancer6 studies
- Diabetic Foot5 studies
- Ovarian Cancer4 studies
- Stomach Cancer4 studies
- Ulcerative Colitis4 studies
- Small Cell Lung Cancer4 studies
- Crohn's Disease4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.